Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.8B
1-Year Est. Return 50.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Est. Return
1 Year Est. Return
+50.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$75.8B
AUM Growth
+$582M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,038
New
Increased
Reduced
Closed

Top Buys

1 +$633M
2 +$487M
3 +$419M
4
META icon
Meta Platforms (Facebook)
META
+$345M
5
KO icon
Coca-Cola
KO
+$257M

Top Sells

1 +$1.36B
2 +$900M
3 +$583M
4
NVDA icon
NVIDIA
NVDA
+$335M
5
NFLX icon
Netflix
NFLX
+$320M

Sector Composition

1 Technology 21.72%
2 Healthcare 15.16%
3 Consumer Discretionary 11.8%
4 Communication Services 10.53%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IIIV icon
3676
i3 Verticals
IIIV
$583M
-12,000
IIPR icon
3677
Innovative Industrial Properties
IIPR
$1.37B
-4,400
INBS icon
3678
Intelligent Bio Solutions
INBS
$6.25M
-10,900
INZY
3679
DELISTED
Inozyme Pharma
INZY
-470,500
IOT icon
3680
Samsara
IOT
$21.5B
-931,162
IOVA icon
3681
Iovance Biotherapeutics
IOVA
$984M
-4,887,200
IQV icon
3682
IQVIA
IQV
$39.5B
-103,047
ITOS
3683
DELISTED
iTeos Therapeutics
ITOS
-602,100
IVE icon
3684
iShares S&P 500 Value ETF
IVE
$46.5B
-4,100
IVOO icon
3685
Vanguard S&P Mid-Cap 400 ETF
IVOO
$2.89B
-7,600
IVV icon
3686
iShares Core S&P 500 ETF
IVV
$721B
-1,200
IVW icon
3687
iShares S&P 500 Growth ETF
IVW
$66.1B
-37,700
IVZ icon
3688
Invesco
IVZ
$10.8B
-442,600
IWN icon
3689
iShares Russell 2000 Value ETF
IWN
$11.7B
-6,900
IWX icon
3690
iShares Russell Top 200 Value ETF
IWX
$3B
-9,800
IXUS icon
3691
iShares Core MSCI Total International Stock ETF
IXUS
$50.4B
-25,100
JBGS
3692
JBG SMITH
JBGS
$1.08B
-117,800
JEF icon
3693
Jefferies Financial Group
JEF
$11.7B
-537,589
JHG icon
3694
Janus Henderson
JHG
$6.6B
-254,300
JIRE icon
3695
JPMorgan International Research Enhanced Equity ETF
JIRE
$9.34B
-10,100
JMST icon
3696
JPMorgan Ultra-Short Municipal Income ETF
JMST
$5.48B
-813,890
JNPR
3697
DELISTED
Juniper Networks
JNPR
-1,090,291
JOBY icon
3698
Joby Aviation
JOBY
$12.7B
-4,133,800
JOE icon
3699
St. Joe Company
JOE
$3.52B
-9,000
JXN icon
3700
Jackson Financial
JXN
$6.6B
-126,200